2006 Symposium Highlights

Translational Medicine and Therapeutics:
The Future of Drug Development

May 5-6, 2006

 The College of Integrated Life Sciences: an Academic Model for Fostering Translational Research (pdf)
Edward Holmes, M.D., Vice Chancellor, UCSD (University of California, San Diego)
 αllb β3 Antagonists As An Example of Translational Medicine Therapeutics (pdf)
Barry Coller, M.D., Physician in Chief, Rockefeller University
 Prescribing by Genotype Are We There Yet? (pdf)
Alastair Wood, M.D., Associate Dean, Vanderbilt University School of Medicine
 Cell and Gene Therapies: Challenges in Developing Paradigms for Analyzing Novel Therapeutics (pdf)
Kathy High, M.D., Ph.D., Investigator, HHMI, University of Pennsylvania School of Medicine
The Emerging Era of Translational Medicine and Therapeutics
Garret FitzGerald, M.D., Director, ITMAT, Chair, Department of Pharmacology, University of Pennsylvania
 Translational Studies in Heart Failure (pdf)
Walter Koch, Ph.D., Director, Center for Translational Medicine, Thomas Jefferson University
 Today's Discoveries, Tomorrow's Cures? A Convergence of Cultures (pdf)
Ellen Puré, Ph.D., Wistar and Ludwig Institutes
Integrated Clinical Research Informatics for Translational Medicine and Therapeutics (pdf)
J. Richard Landis, Ph.D., Professor of Biostatistics, University of Pennsylvania
The Greater Philadelphia Bioinformatics Alliance: Technology Collaboration for Training and Discovery (pdf)
J. Robert Beck, M.D., Vice President and Deputy Director of Population Science, Fox Chase Cancer Center
Fostering Innovation: A Government Perspective (pdf)
Mary Harney, TD, Tánaiste and Minister for Health and Children, Government of Ireland
FDA's Critical Path Initiative and Translational Research (pdf)
Janet Woodcock, M.D., Acting Deputy Commissioner for Operations, FDA
 Revitalising Clinical Investigation, Who, How and Where? (pdf)
Sir Colin Dollery, M.D., Senior Advisor, GlaxoSmithKline
Making Pharma Sector Investment More Attractive — Why the Business Model Needs to Change? (pdf)
Sophia Tickell, BA, Director of Pharma Futures II, and Chair, SustainAbility
Improving Dugs and Development by Technology (pdf)
Thomas Caskey, M.D., Managing Director, Cogene Ventures
VEGF Trap in Clinical Trials Today, and VelociGene Coupled with VelocImmune for Drug Trials of Tomorrow (pdf)
George Yancopoulis, M.D., Ph.D., Chief Scientific Officer, Regeneron
 Labors of Love: Science Serving the Public Good (pdf)
Jerome Strauss, M.D., Ph.D., Dean VCU School of Medicine, Virginia Commonweath University